RA Capital’s SPAC Merger Bet The biopharma specialist could be signaling renewed confidence in the overall VC market. Stephen Taub November 28, 2022
This content is from: Premium The Critical Role of DC Plan Sponsors Right Now Sponsored by BlackRock September 16, 2022
Druckenmiller Expands His Stock Portfolio The legendary macro trader’s Duquesne Family Office made several new buys and slashed several key positions in the third quarter. Stephen Taub November 17, 2022
Biopharma Funds Regain Some Health At least one fund is in the black, and several others moved closer to breakeven in October. Stephen Taub November 17, 2022
Tiger Funds Made Big Moves in the Third Quarter Repositioning was the name of the game for D1 Capital, Tiger Global, Lone Pine, Viking, Coatue, and others. Stephen Taub November 16, 2022
Sponsored Is Shipping Cost Inflation About to Peak? Relief is in sight for companies that rely on trucking. Sponsored by William Blair Investment Management October 11, 2022
Skye Global Slashes Its Stake in a Key Company The heavily concentrated fund led by Jamie Sterne extended its huge loss in October. Stephen Taub November 15, 2022
How Valiant Avoided Disaster Tiger Grandcub Chris Hansen explains the firm’s relative success in 2022 — and why he worries about the market’s next moves. Stephen Taub November 14, 2022
Third Point Slashes Its Stake in SentinelOne The firm has now sharply reduced its positions in three once-private investments. Stephen Taub November 11, 2022
Sponsored Leveraging Digitized Banking in Pursuit of Real-Time Payments Technological advancement has many benefits, but secure and instantaneous cross-border payments are high on the list of goals. Sponsored by Northern Trust October 07, 2022
